{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:33:12Z","timestamp":1789399992813,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113\\u20132628- B-006\\u2013006-MY3"],"award-info":[{"award-number":["NSTC 113\\u20132628- B-006\\u2013006-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijpddr.2025.100586","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:20:07Z","timestamp":1740158407000},"page":"100586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Recent in vitro advances in the ocular antimicrobial agents against Acanthamoeba"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4496-3544","authenticated-orcid":false,"given":"Chun-Hsien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-488X","authenticated-orcid":false,"given":"Jian-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-9429","authenticated-orcid":false,"given":"Yu-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7223-5931","authenticated-orcid":false,"given":"Wei-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2025.100586_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13568-020-01061-z","article-title":"Metronidazole conjugated magnetic nanoparticles loaded with amphotericin B exhibited potent effects against pathogenic Acanthamoeba castellanii belonging to the T4 genotype","volume":"10","author":"Abdelnasir","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.ijpddr.2025.100586_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clae.2015.11.004","article-title":"Targeting cyst wall is an effective strategy in improving the efficacy of marketed contact lens disinfecting solutions against Acanthamoeba castellanii cysts","volume":"39","author":"Abjani","year":"2016","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.ijpddr.2025.100586_bib3","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11686-024-00891-2","article-title":"Metal oxide nanoparticles exhibit anti-Acanthamoeba castellanii properties by inducing necrotic cell death","volume":"69","author":"Ahmed","year":"2024","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2023.108474","article-title":"Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics","volume":"246","author":"Akbar","year":"2023","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199243020-00010","article-title":"Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses","volume":"43","author":"Balfour","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.ijpddr.2025.100586_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/1973947815Y.0000000068","article-title":"Antimicrobials therapy of anaerobic infections","volume":"28","author":"Brook","year":"2016","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00003226-199403000-00013","article-title":"Acanthamoeba keratitis. Resolution after epithelial debridement","volume":"13","author":"Brooks","year":"1994","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/aem.44.2.491-493.1982","article-title":"Amoebae from antarctic soil and water","volume":"44","author":"Brown","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2025.100586_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jof5010010","article-title":"The \u2018amoeboid predator-fungal animal virulence\u2019hypothesis","volume":"5","author":"Casadevall","year":"2019","journal-title":"Journal of Fungi"},{"key":"10.1016\/j.ijpddr.2025.100586_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.004","article-title":"Characterisation of the beta-lactam resistance enzyme in Acanthamoeba castellanii","volume":"55","author":"Chen","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2025.100586_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ijpddr.2025.100586_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00417-003-0805-7","article-title":"Delay in diagnosis and outcome of Acanthamoeba keratitis","volume":"242","author":"Claerhout","year":"2004","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ijpddr.2025.100586_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2009.06.009","article-title":"Acanthamoeba keratitis: diagnosis and treatment update 2009","volume":"148","author":"Dart","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/infdis\/163.4.916","article-title":"Protective and curative effects of rifampicin in Acanthamoeba meningitis of the mouse","volume":"163","author":"Das","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100586_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0000000000002880","article-title":"Therapeutic corneal transplantation in Acanthamoeba keratitis: penetrating versus lamellar keratoplasty","volume":"41","author":"Di Zazzo","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105830","article-title":"Derivatisation of metronidazole enhances cytotoxic effect against Acanthamoeba genotype T4 isolates and leads to cytomorphological changes in trophozoites","volume":"216","author":"Dusekova","year":"2021","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2025.100586_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/31.1.9","article-title":"Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action","volume":"31","author":"Edwards","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/OPTH.S181997","article-title":"Treatment-resistant bacterial keratitis: challenges and solutions","volume":"14","author":"Egrilmez","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib21","first-page":"1059","article-title":"A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis","volume":"35","author":"Elder","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpddr.2025.100586_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00731-23","article-title":"Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis","volume":"68","author":"Escrig","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study","volume":"32","author":"Foulks","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","article-title":"Risk factors and causative organisms in microbial keratitis","volume":"27","author":"Green","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.8.5.17","article-title":"In vitro evaluation of the inhibitory effect of topical ophthalmic agents on Acanthamoeba viability","volume":"8","author":"Heaselgrave","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ijpddr.2025.100586_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpddr.2016.11.001","article-title":"The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage","volume":"6","author":"Huang","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2025.100586_bib27","article-title":"Acanthamoeba-associated retinitis successfully treated with intravitreal and systemic antimicrobials","volume":"32","author":"Huang","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ijpddr.2025.100586_bib28","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/AAC.02635-14","article-title":"Cysticidal activity of antifungals against different genotypes of Acanthamoeba","volume":"58","author":"Iovieno","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00436-014-4302-1","article-title":"Tigecycline inhibits proliferation of Acanthamoeba castellanii","volume":"114","author":"Jha","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2025.100586_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3126\/nepjoph.v13i1.29912","article-title":"Acanthamoeba keratitis - a case report","volume":"13","author":"Joshi","year":"2021","journal-title":"Nepal. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00333-19","article-title":"Symbiont-mediated defense against Legionella pneumophila in amoebae","volume":"10","author":"K\u00f6nig","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2025.100586_bib32","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijpddr.2025.100586_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jop.2018.0089","article-title":"Challenges in the polyene- and azole-based pharmacotherapy of ocular fungal infections","volume":"35","author":"Lakhani","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ijpddr.2025.100586_bib34","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jac\/dkab016","article-title":"Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis","volume":"76","author":"Le Roy","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib35","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0190-9622(98)70483-9","article-title":"Pharmacokinetics and pharmacology of terbinafine and itraconazole","volume":"38","author":"Leyden","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib36","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/AAC.00329-10","article-title":"Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba","volume":"54","author":"Lorenzo-Morales","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib37","article-title":"Antiamoebic properties of ceftriaxone and zinc-oxide-cyclodextrin-conjugated ceftriaxone","volume":"11","author":"Makhlouf","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijpddr.2025.100586_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/CMR.16.2.273-307.2003","article-title":"Acanthamoeba spp. as agents of disease in humans","volume":"16","author":"Marciano-Cabral","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2025.100586_bib39","first-page":"733","article-title":"Experimental Acanthamoeba infections in mice pretreated with methylprednisolone or tetracycline","volume":"92","author":"Markowitz","year":"1978","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib40","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00417-013-2371-y","article-title":"Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba","volume":"251","author":"Martin-Navarro","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib41","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/AAC.00066-15","article-title":"Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii","volume":"59","author":"Martin-Navarro","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/ICO.0000000000000804","article-title":"Update on Acanthamoeba keratitis: diagnosis, treatment, and outcomes","volume":"35","author":"Maycock","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib43","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41433-021-01768-8","article-title":"Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium","volume":"36","author":"Megha","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijpddr.2025.100586_bib44","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/s41433-023-02404-3","article-title":"Analysis of microbial keratitis incidence, isolates and in-vitro antimicrobial susceptibility in the East of England: a 6-year study","volume":"37","author":"Moledina","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijpddr.2025.100586_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AEM.71.1.20-28.2005","article-title":"Amoebae as training grounds for intracellular bacterial pathogens","volume":"71","author":"Molmeret","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2019.02.008","article-title":"Fungal Lanosterol 14alpha-demethylase: a target for next-generation antifungal design","volume":"1868","author":"Monk","year":"2020","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.ijpddr.2025.100586_bib47","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/ICO.0000000000000642","article-title":"Potential value of cellulose synthesis inhibitors combined with PHMB in the treatment of Acanthamoeba keratitis","volume":"34","author":"Moon","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib48","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1039\/D1MD00200G","article-title":"beta-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates","volume":"12","author":"Mora-Ochomogo","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100586_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/575297","article-title":"Detection of free-living amoebae using amoebal enrichment in a wastewater treatment plant of Gauteng Province, South Africa","volume":"2014","author":"Muchesa","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ijpddr.2025.100586_bib50","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/ICO.0000000000002315","article-title":"Topical voriconazole as supplemental treatment for Acanthamoeba keratitis","volume":"39","author":"Musayeva","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.ijpddr.2025.100586_bib51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jop.2017.0033","article-title":"Evaluation of in vitro antiamoebic activity of antimicrobial agents against clinical Acanthamoeba isolates","volume":"33","author":"Nakaminami","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ijpddr.2025.100586_bib52","first-page":"181","article-title":"Occurrence of potentially pathogenic bacterial-endosymbionts in Acanthamoeba spp","volume":"10","author":"Niyyati","year":"2015","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.arcmed.2006.02.007","article-title":"In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri","volume":"37","author":"Ondarza","year":"2006","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijpddr.2025.100586_bib54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijantimicag.2017.03.033","article-title":"In-vitro development of an effective treatment for Acanthamoeba keratitis","volume":"50","author":"Ortilles","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl. 5","key":"10.1016\/j.ijpddr.2025.100586_bib55","doi-asserted-by":"crossref","first-page":"S431","DOI":"10.1093\/clind\/13.Supplement_5.S431","article-title":"In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba","volume":"13","author":"Osato","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100586_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","article-title":"Triazole antifungals: a review","volume":"51","author":"Peyton","year":"2015","journal-title":"Drugs Today"},{"key":"10.1016\/j.ijpddr.2025.100586_bib58","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.2147\/OPTH.S438990","article-title":"Impact of first healthcare provider on Acanthamoeba keratitis course: how to overcome poor prognosis in Acanthamoeba keratitis treatment? A single tertiary center, observational study","volume":"17","author":"Przybek-Skrzypecka","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib59","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/acschemneuro.9b00289","article-title":"Oleic acid coated silver nanoparticles showed better in vitro amoebicidal effects against naegleria fowleri than amphotericin B","volume":"11","author":"Rajendran","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpddr.2025.100586_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00203-024-03854-3","article-title":"Self-assembled micelles loaded with itraconazole as anti-Acanthamoeba nano-formulation","volume":"206","author":"Rao","year":"2024","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib61","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00436-022-07650-0","article-title":"Combinatorial treatment with beta-glucanase enzyme and chlorhexidine induces cysticidal effects in Acanthamoeba cyst","volume":"121","author":"Rased","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2025.100586_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100025","article-title":"In vitro comparison of the Acanthamoeba cysticidal activity of povidone iodine, natamycin, and chlorhexidine","volume":"1","author":"Redd","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ijpddr.2025.100586_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00203-023-03536-6","article-title":"Eye fungal infections: a mini review","volume":"205","author":"Reginatto","year":"2023","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib64","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0161-6420(92)31823-8","article-title":"Enhanced killing of Acanthamoeba cysts in vitro using dimethylsulfoxide","volume":"99","author":"Saunders","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpddr.2025.100586_bib65","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00436-014-3932-7","article-title":"Relevance of free-living amoebae as hosts for phylogenetically diverse microorganisms","volume":"113","author":"Scheid","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2025.100586_bib66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1550-7408.1998.tb04557.x","article-title":"Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas","volume":"45","author":"Schuster","year":"1998","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/14787210.1.2.205","article-title":"Treatment of Acanthamoeba keratitis","volume":"1","author":"Seal","year":"2003","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2025.100586_bib68","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.eye.6700563","article-title":"Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment","volume":"17","author":"Seal","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijpddr.2025.100586_bib69","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/aos.14792","article-title":"Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre","volume":"99","author":"Shah","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2024.100550","article-title":"Ouabain, ATPase inhibitor, potentially enhances the effect of polyhexamethylene biguanide on Acanthamoeba castellanii","volume":"25","author":"Shih","year":"2024","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2025.100586_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02223-19","article-title":"The antifungal drug isavuconazole is both amebicidal and cysticidal against Acanthamoeba castellanii","volume":"64","author":"Shing","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100586_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s10123-024-00584-w","article-title":"The potential of nanocomposites (patuletin-conjugated with gallic acid-coated zinc oxide) against free-living amoebae pathogens","author":"Siddiqui","year":"2024","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ophtha.2005.10.041","article-title":"Acanthamoeba keratitis: clinical characteristics and management","volume":"113","author":"Sun","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpddr.2025.100586_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joco.2018.09.008","article-title":"Acanthamoeba keratitis - clinical signs, differential diagnosis and treatment","volume":"31","author":"Szentmary","year":"2019","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.ijpddr.2025.100586_bib75","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpddr.2017.09.002","article-title":"In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B","volume":"7","author":"Taravaud","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2025.100586_bib76","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1128\/AEM.72.4.2428-2438.2006","article-title":"Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network","volume":"72","author":"Thomas","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib77","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1038\/s41598-017-07495-z","article-title":"Characterisation of sterol biosynthesis and validation of 14alpha-demethylase as a drug target in Acanthamoeba","volume":"7","author":"Thomson","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2025.100586_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10792-019-01188-4","article-title":"Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts","volume":"40","author":"Thongseesuksai","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib79","first-page":"665","article-title":"Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide","volume":"15","author":"Tien","year":"1999","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.ijpddr.2025.100586_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1051\/parasite\/2010171067","article-title":"Free-living Amoebae (FLA): morphological and molecular identification of Acanthamoeba in dental unit water","volume":"17","author":"Trabelsi","year":"2010","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2025.100586_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101031","article-title":"Bacterial keratitis: identifying the areas of clinical uncertainty","volume":"89","author":"Tuft","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ijpddr.2025.100586_bib82","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2008.298","article-title":"Fungal keratitis in the United Kingdom 2003-2005","volume":"23","author":"Tuft","year":"2009","journal-title":"Eye (Lond)"},{"issue":"Suppl. 2","key":"10.1016\/j.ijpddr.2025.100586_bib83","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpddr.2025.100586_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/713687","article-title":"Antifungal resistance and new strategies to control fungal infections","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.ijpddr.2025.100586_bib85","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0002-9394(14)74448-4","article-title":"Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide","volume":"115","author":"Varga","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib86","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","article-title":"How macrolide antibiotics work","volume":"43","author":"Vazquez-Laslop","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijpddr.2025.100586_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2007.00232.x","article-title":"Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea","volume":"50","author":"Visvesvara","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib88","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2147\/OPTH.S13672","article-title":"Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium","volume":"4","author":"Watanabe","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2180-6-63","article-title":"Interaction between Mycobacterium avium subsp. paratuberculosis and environmental protozoa","volume":"6","author":"Whan","year":"2006","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib90","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2008.04.019","article-title":"Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China","volume":"146","author":"Xie","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib91","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2006.05.035","article-title":"Spectrum of fungal keratitis in north China","volume":"113","author":"Xie","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpddr.2025.100586_bib92","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0002-9394(03)00635-4","article-title":"Acanthamoeba keratitis as a complication of orthokeratology","volume":"136","author":"Xuguang","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2025.100586_bib93","first-page":"201","article-title":"Acanthamoeba keratitis presenting as dendritic keratitis in a soft contact lens wearer","volume":"25","author":"Yeung","year":"2002","journal-title":"Chang Gung Med. J."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:19:21Z","timestamp":1751930361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":93,"alternative-id":["S2211320725000090"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100586","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent in vitro advances in the ocular antimicrobial agents against Acanthamoeba","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100586"}}